Ruopeng Su, Zeyu Chen, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hailong Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
INTRODUCTION: The effectiveness and safety of immune checkpoint inhibitor (ICI) monotherapy in advanced upper tract urothelial carcinoma (UTUC) is less reported. METHODS: In total, 106 consecutive advanced UTUC patients receiving ICI monotherapy were collected from nine high volume centers. Clinical outcomes were analyzed according to multiple parameters (e.g., treatment line, metastatic sites). Objective response rate (ORR), overall survival (OS) and progression-free survival (PFS) were captured after ICI initiation...
March 23, 2023: Cancer Medicine